ACCENTIA BIOPHARMACEUTICALS INC Increase (Decrease) in Accounts Payable
ACCENTIA BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accounts Payable of $465.85 thousand for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for the quarter ending 2012-09-30 was $249.74K.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for the quarter ending 2012-06-30 was -$167.19K.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for the quarter ending 2012-03-31 was $112.99K, a 227.30% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for the quarter ending 2011-12-31 was $270.31K, a 48.21% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for fiscal 2012 was $465.85K, a 2.98% decline from fiscal 2011.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for fiscal 2011 was $480.18K.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accounts payable for fiscal 2010 was -$741.31K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2012-09-30 | $249.74K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $82.56K derived: sum of 2 quarters · filed 2012-12-26 | $195.54K derived: sum of 3 quarters · filed 2012-12-26 | $465.85K 10-K · filed 2012-12-26 |
| 2012-06-30 | -$167.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | -$54.20K derived: sum of 2 quarters · filed 2012-08-14 | $216.11K 10-Q · filed 2012-08-14 | $193.42K derived: sum of 4 quarters · filed 2012-12-26 |
| 2012-03-31 | $112.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $383.30K 10-Q · filed 2012-05-15 | $360.61K derived: sum of 3 quarters · filed 2012-12-26 | $306.99K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-12-31 | $270.31K 10-Q · filed 2012-02-10 | $247.62K derived: sum of 2 quarters · filed 2012-12-26 | $194.01K derived: sum of 3 quarters · filed 2012-12-26 | $228.53K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-09-30 | -$22.69K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | -$76.30K derived: sum of 2 quarters · filed 2012-12-26 | -$41.78K derived: sum of 3 quarters · filed 2012-12-26 | $480.18K 10-K · filed 2012-12-26 |
| 2011-06-30 | -$53.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | -$19.09K derived: sum of 2 quarters · filed 2012-08-14 | $502.87K 10-Q · filed 2012-08-14 | $648.81K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $34.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $556.48K 10-Q · filed 2012-05-15 | $702.43K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $521.96K 10-Q · filed 2012-02-10 | $667.91K derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | $145.95K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19 | -$741.31K 10-K · filed 2011-12-19 | ||
| 2010-06-30 | -$887.25K 10-Q · filed 2011-08-12 |